My knowledge of doctors and hospitals in Japan is above average, having lived here for 46 years while working in the health care industry and receiving medical care, including four operations, says long-time Japanese industry watcher P Reed Maurer, president of International Alliances Limited. But this year I experienced total immersion in the system and came out fully convinced it works both medically and economically. This is the story.
Initial diagnosis
In February at the Jikei University Hospital I was diagnosed with vocal-chord cancer, a squamous cell carcinoma. My first lesson was to appreciate the conservative nature of Japanese physicians. Vocal-chord cancer can be observed by putting a camera up the nose and down the throat but that was not enough.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze